#	Aladdin ID	Assay Type	Description	Organism	Compounds	Reference	BAO Format	Source
1.	ALA4742505	Binding	Inhibition of CDK19(CDK11) (unknown origin) assessed as residual ligand binding level at 10000 nM relative to control	Homo sapiens	1	ALA4742393	single protein format	Patent Bioactivity Data
2.	ALA4742506	Binding	Inhibition of CSNK1A1 (unknown origin) assessed as residual ligand binding level at 10000 nM relative to control	Homo sapiens	1	ALA4742393	single protein format	Patent Bioactivity Data
3.	ALA4742507	Binding	Inhibition of CSNK1A1L (unknown origin) assessed as residual ligand binding level at 10000 nM relative to control	Homo sapiens	1	ALA4742393	single protein format	Patent Bioactivity Data
4.	ALA4742508	Binding	Inhibition of CSNK1D (unknown origin) assessed as residual ligand binding level at 10000 nM relative to control	Homo sapiens	1	ALA4742393	single protein format	Patent Bioactivity Data
5.	ALA4742509	Binding	Inhibition of CSNK1E (unknown origin) assessed as residual ligand binding level at 10000 nM relative to control	Homo sapiens	1	ALA4742393	single protein format	Patent Bioactivity Data
6.	ALA4742510	Binding	Inhibition of CSNK1G1 (unknown origin) assessed as residual ligand binding level at 10000 nM relative to control	Homo sapiens	1	ALA4742393	single protein format	Patent Bioactivity Data
7.	ALA4742511	Binding	Inhibition of CSNK1G2 (unknown origin) assessed as residual ligand binding level at 10000 nM relative to control	Homo sapiens	1	ALA4742393	single protein format	Patent Bioactivity Data
8.	ALA4742512	Binding	Inhibition of CSNK1G3 (unknown origin) assessed as residual ligand binding level at 10000 nM relative to control	Homo sapiens	1	ALA4742393	single protein format	Patent Bioactivity Data
9.	ALA4742513	Binding	Inhibition of DAPK1 (unknown origin) assessed as residual ligand binding level at 10000 nM relative to control	Homo sapiens	1	ALA4742393	single protein format	Patent Bioactivity Data
10.	ALA4742514	Binding	Inhibition of DYRK1A (unknown origin) assessed as residual ligand binding level at 10000 nM relative to control	Homo sapiens	1	ALA4742393	single protein format	Patent Bioactivity Data
11.	ALA4742515	Binding	Inhibition of DYRK1B (unknown origin) assessed as residual ligand binding level at 10000 nM relative to control	Homo sapiens	1	ALA4742393	single protein format	Patent Bioactivity Data
12.	ALA4742516	Binding	Inhibition of DYRK2 (unknown origin) assessed as residual ligand binding level at 10000 nM relative to control	Homo sapiens	1	ALA4742393	single protein format	Patent Bioactivity Data
13.	ALA4742517	Binding	Inhibition of GCN2 kinase domain 2 5808G mutant (unknown origin) assessed as residual ligand binding level at 10000 nM relative to control	Homo sapiens	1	ALA4742393	assay format	Patent Bioactivity Data
14.	ALA4742518	Binding	Inhibition of HIPK1 (unknown origin) assessed as residual ligand binding level at 10000 nM relative to control	Homo sapiens	1	ALA4742393	single protein format	Patent Bioactivity Data
15.	ALA4742519	Binding	Inhibition of p38-alpha (unknown origin) assessed as residual ligand binding level at 10000 nM relative to control	Homo sapiens	1	ALA4742393	single protein format	Patent Bioactivity Data
16.	ALA4742520	Binding	Inhibition of PIM1 (unknown origin) assessed as residual ligand binding level at 10000 nM relative to control	Homo sapiens	1	ALA4742393	single protein format	Patent Bioactivity Data
17.	ALA4742521	Binding	Inhibition of RSK4 c-terminal kinase domain (unknown origin) assessed as residual ligand binding level at 10000 nM relative to control	Homo sapiens	1	ALA4742393	single protein format	Patent Bioactivity Data
18.	ALA4742522	Binding	Inhibition of TGFBR1 (unknown origin) assessed as residual ligand binding level at 10000 nM relative to control	Homo sapiens	1	ALA4742393	single protein format	Patent Bioactivity Data
19.	ALA4742525	Functional	Induction of rescue of anemia in RPS19-deficient mouse model for DBA assessed as improvement in erythrocytes production at 10 mg/kg, po dosed every 12 hrs for 5 times and measured 48 hrs after last dose	Mus musculus	12	ALA4742393	organism-based format	Patent Bioactivity Data
20.	ALA4742530	Binding	Inhibition of CDK8/CDK19 assessed as rescue of proliferation of RPS19-deficient mouse erythroid progenitor cells by cell-based phenotypic screening assay	Mus musculus	12	ALA4742393	tissue-based format	Patent Bioactivity Data